NAOV — NanoVibronix Cashflow Statement
0.000.00%
Last trade - 00:00- $2.23m
- -$1.06m
- $2.28m
- 28
- 62
- 22
- 30
Annual cashflow statement for NanoVibronix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.79 | -4.33 | -14.3 | -5.45 | -3.71 |
| Depreciation | |||||
| Non-Cash Items | 2.36 | 0.487 | 10.4 | 0.717 | 0.43 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.447 | 0.445 | -0.494 | -2.31 | -0.322 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.87 | -3.39 | -4.37 | -7.04 | -3.6 |
| Capital Expenditures | 0 | -0.002 | -0.003 | -0.003 | -0.001 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | 0 | -0.002 | -0.003 | -0.003 | -0.001 |
| Financing Cash Flow Items | -0.475 | — | -0.388 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.32 | 9.52 | 4.58 | 2.09 | 4.22 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.442 | 6.2 | 0.204 | -5.02 | 0.57 |